(IN BRIEF) Boehringer Ingelheim and IBM have formed a partnership to expedite the discovery of novel candidate antibodies for therapeutic purposes. Boehringer will utilize IBM’s foundation model technologies, combining them with their proprietary data to enhance the antibody discovery process. … Read the full press release →
20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin). In this study of adult patients with … Read the full press release →
Posted in Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged anti-diabetic therapies, AstraZeneca, autoimmune, biopharmaceutical, biopharmaceutical business, Bristol-Myers Squibb, cardiovascular, cardiovascular death, cardiovascular disease, clinical trial, Diabetes Mellitus, Hadassah University Medical Center, infection, inflammation, metabolic, neuroscience diseases, non-fatal ischaemic stroke, non-fatal myocardial infarction, oncology, Onglyza, prescription medicines, respiratory, SAVOR-TIMI-53, saxagliptin, TIMI Study Group, type 2 diabetes
Load more...
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
BevZero South Africa Achieves FSSC 22000 Food Safety Certification
Digi Spain Enters Agreement to Sell FTTH Network to International Investors for Up to EUR 750 Million
Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
Cybersecurity across Europe in the last quarter (1 Dec 2023 – 1 Mar 2024)
Hamburg-based LogTech company driveMybox expands to Hungary
What’s new in cancer care across Europe in early 2024
The European companies at MWC Barcelona 2024: AI, 5G, VR, XR, Cybersecurity, etc.
Digi Communications NV 2023 Preliminary Financial Results
THE LATEST ON QUANTUM COMPUTING IN EUROPE
DIGI COMMUNICATIONS NV INVESTORS CALL ON 2023 PRELIMINARY FINANCIAL RESULTS
AI IN JAN 2024 ACROSS EUROPE
LENSA СТЪПВА НА БЪЛГАРСКИЯТ ПАЗАР
CRIANDO O FUTURO: DESENVOLVIMENTO DA AENO NO MERCADO DE CONSUMO EM PORTUGAL
DIGI COMMUNICATIONS N.V. 2024 FINANCIAL CALENDAR
CDP INDUSTRY UPDATE JAN 2024
ECARSTRADE ANNONCE DIRK VAN ROOST AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER
NEXT-GEN DEALCOHOLIZATION TECHNOLOGY
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
KUKA LAUNCHES VERSATILE KR FORTEC INDUSTRIAL ROBOT WITH EXTENDED ARM
VIRTUAL ASSISTANT WITH GENERATIVE AI FOR HYPER-PERSONALIZED IN-CAR EXPERIENCE
